Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05162846 · ClinicalTrials.gov registry record · NA
Michigan Genetic Hereditary Testing (MiGHT)
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 831
- Enrollment target
NCT05162846 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 831 participants.
The verdict
NCT05162846, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 831 participants
- Enrollment target
Study Summary
The primary purpose of this study is to compare three interventions, two experimental and one standard of care (usual care), to see if the experimental interventions will increase the likelihood of a participant obtaining guideline-concordant genetic testing. Eligible participants will be randomized (assigned) to one of the following interventions: 1) Virtual genetics navigator, a mobile-optimized website, designed by the investigators, that delivers tailored messages and content; 2) two motivational interviewing (MI) telephone calls delivered by trained genetics health coaches; or 3) usual care.
Interventions
- BEHAVIORAL Motivational interviewing (MI)
- OTHER Publicly available genetic testing resources
- BEHAVIORAL Virtual genetics navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 831 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2025-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05162846
The ClinicalTrials.gov registry entry for NCT05162846 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 831 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Motivational interviewing (MI) is the first listed.
NCT05162846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05162846 about?
NCT05162846 is a clinical study titled "Michigan Genetic Hereditary Testing (MiGHT)". The primary purpose of this study is to compare three interventions, two experimental and one standard of care (usual care), to see if the experimental interventions will increase the likelihood of a participant obtaining guideline-concordant genetic testing. Eligible participants will be randomized...
What is the current status of trial NCT05162846?
This trial is currently completed. It is a NA study. The enrollment target is 831 participants. The study started on 2022-04-21. Estimated completion is 2025-11-21.
What interventions are being tested in trial NCT05162846?
The interventions under investigation include: Motivational interviewing (MI) (BEHAVIORAL), Publicly available genetic testing resources (OTHER), Virtual genetics navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT05162846?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.